NCCR-Synapsy

The Synaptic Bases of Mental Diseases

A new tool for discovering nanoporous materials

nanoporous

EPFL scientists have developed a mathematical “face-recognition” method for identifying and discovering nanoporous materials based on their pore size. Materials classified as “nanoporous” have structures (or “frameworks”) with pores up to 100 nm in diameter. These include diverse materials used in different Read more…


3D Imaging removes secrets of communication between brain cells

3D-Imaging

Prof. Andrea Volterra and his team from the Department of Fundamental Neuroscience (UNIL) have pioneered a new approach allowing correct study of astrocyte-synapse-blood vessel interactions: 3D volumetric two-photon imaging. This method enables an unprecedented, comprehensive view of the multiform astrocyte Read more…


GliaPharm moves to Campus Biotech

gliapharm team

C. Finsterwald, A. Magistretti, P. Magistretti, S. Lengacher GliaPharm, tackling Stephen Hawking’s disease, moves to Campus Biotech, Geneva. There are approximately 800 people working in the Campus Biotech building, say its promoteurs. However, some floors of the Lemanic pole dedicated Read more…


Immersive virtual-reality creation software for everyone

VR software

IMVERSE, an EPFL spinoff, has developed a software that lets users convert 360-degree images from 2D into 3D and both manipulate and create virtual-reality content in real time with the help of virtual-reality glasses. The system will be unveiled at Read more…


Charles Quairiaux awarded by the Swiss League Against Epilepsy

epi-quairieux

The research grant 2017 from the Swiss League Against Epilepsy goes to Dr. Charles Quairiaux, Dr. Abbas Khani and Prof. Christoph Michel of the Department of Basic Neurosciences of the University of Geneva for their project entitled: “Decreasing susceptibility of Read more…